These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9671212)

  • 1. Tumor necrosis factor beta and soluble APO-1/Fas independently predict progression to AIDS in HIV-seropositive patients.
    Medrano FJ; Leal M; Arienti D; Rey C; Zagliani A; Torres Y; Sanchez-Quijano A; Lissen E; Clerici M
    AIDS Res Hum Retroviruses; 1998 Jul; 14(10):835-43. PubMed ID: 9671212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number.
    Dockrell DH; Badley AD; Algeciras-Schimnich A; Simpson M; Schut R; Lynch DH; Paya CV
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1509-18. PubMed ID: 10580401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
    Farzadegan H; Henrard DR; Kleeberger CA; Schrager L; Kirby AJ; Saah AJ; Rinaldo CR; O'Gorman M; Detels R; Taylor E; Phair JP; Margolick JB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):448-55. PubMed ID: 8970472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine.
    Jacobson MA; De Gruttola V; Reddy M; Arduino JM; Strickland S; Reichman RC; Bartlett JA; Phair JP; Hirsch MS; Collier AC
    AIDS; 1995 Jul; 9(7):727-34. PubMed ID: 7546418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
    Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F
    Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV-infected injection drug users.
    Zabay JM; Sempere JM; Benito JM; Gonzalez B; Obregón E; Díez J; Fernández-Cruz E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):266-72. PubMed ID: 7859138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection.
    Lifson AR; Hessol NA; Buchbinder SP; O'Malley PM; Barnhart L; Segal M; Katz MH; Holmberg SD
    Lancet; 1992 Jun; 339(8807):1436-40. PubMed ID: 1351128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viraemia and p24 antigenaemia are independent risk factors for the emergency of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection.
    Relimpio F; Rey C; Pineda JA; Leal M; Caruz A; Sánchez-Quijano A; Lissen E
    Antivir Ther; 1997 Apr; 2(2):99-104. PubMed ID: 11322281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
    Rezza G; Galai N; Pezzotti P; Vlahov D; Graham NM; Viale P; Angarano G
    Antivir Ther; 1997 Jul; 2(3):167-74. PubMed ID: 11322271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.
    Anderson RE; Lang W; Shiboski S; Royce R; Jewell N; Winkelstein W
    Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection.
    Godfried MH; van der Poll T; Weverling GJ; Mulder JW; Jansen J; van Deventer SJ; Sauerwein HP
    J Infect Dis; 1994 Apr; 169(4):739-45. PubMed ID: 7907641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
    Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
    Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
    Halota W; Jaruga B; Pawłowska M
    Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
    Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment.
    Stellbrink HJ; Zöller B; Fenner T; Lichtenberg G; van Lunzen J; Albrecht H; Thiele HG; Greten H
    AIDS; 1996 Jul; 10(8):849-57. PubMed ID: 8828742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection.
    Chironna M; Fanelli M; Potenza D; Serio G; Quarto M
    Int J Clin Lab Res; 1994; 24(2):90-3. PubMed ID: 7919434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection.
    Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.